Cargando…
Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes
INTRODUCTION: One of the examples of genes whose expression can be altered by the action of ustekinumab is TGF-β. It is a pleiotropic cytokine whose activity affects psoriatic changes and the state of homeostasis of the whole organism. AIM: To evaluate the effect of ustekinumab on the transcriptiona...
Autores principales: | Grabarek, Beniamin, Wcisło-Dziadecka, Dominika, Strzałka-Mrozik, Barbara, Gola, Joanna, Plewka, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362746/ https://www.ncbi.nlm.nih.gov/pubmed/34408592 http://dx.doi.org/10.5114/ada.2019.91504 |
Ejemplares similares
-
The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks’ observation
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2021) -
Expression of genes related to inflammation – IL-6, IL-8, and IFN-γ in monitoring ustekinumab therapy: preliminary results
por: Kruszniewska-Rajs, Celina, et al.
Publicado: (2022) -
In silico analysis of CpG islands and miRNAs potentially regulating the JAK-STAT signalling pathway
por: Grabarek, Beniamin O., et al.
Publicado: (2020) -
Variances in the mRNA expression profile of TGF-β1–3 isoforms and its TGF-βRI–III receptors during cyclosporin a treatment of psoriatic patients
por: Michalska-Bańkowska, Anna, et al.
Publicado: (2018) -
Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2020)